Want to see SLDB full AI Analyst Report?
Solid Biosciences (SLDB) Drug Pipeline
| Drug Name | Condition | Stage | Status | Study Name | Trial Start Date | Article |
|---|---|---|---|---|---|---|
| Sgt-003 | Duchenne Muscular Dystrophy | Phase III | Not Yet Recruiting | A Study of SGT-003 Gene Therapy in Ambulant Males With Duchenne Muscular Dystrophy (IMPACT DUCHENNE) | Aug 29, 2025 | ― |
| Sgt-501 | Catecholaminergic Polymorphic Ventricular Tachycardia | Phase I | Not Yet Recruiting | A Study of SGT-501 Gene Therapy in Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT) | Aug 22, 2025 | ― |
| Sgt-212 | Friedreich's Ataxia (Fa) | Phase I | Not Yet Recruiting | A Study of SGT-212 Gene Therapy in Friedreich's Ataxia | Aug 22, 2025 | ― |
| Sgt-003 | Duchenne Muscular Dystrophy | phase1AndPhase2 | Recruiting | A Study of SGT-003 Gene Therapy in Duchenne Muscular Dystrophy (INSPIRE DUCHENNE) | Nov 14, 2023 | ― |
| Sgt-001 | Duchenne Muscular Dystrophy | phase1AndPhase2 | Active Not Recruiting | Microdystrophin Gene Transfer Study in Adolescents and Children With DMD | Dec 05, 2017 | ― |
| Drug Name | Stage | Condition | Status | Study Name | Trial Start Date | Article |
|---|---|---|---|---|---|---|
| Sgt-003 | Phase III | Duchenne Muscular Dystrophy | Not Yet Recruiting | A Study of SGT-003 Gene Therapy in Ambulant Males With Duchenne Muscular Dystrophy (IMPACT DUCHENNE) | Aug 29, 2025 | ― |
| Sgt-501 | Phase I | Catecholaminergic Polymorphic Ventricular Tachycardia | Not Yet Recruiting | A Study of SGT-501 Gene Therapy in Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT) | Aug 22, 2025 | ― |
| Sgt-212 | Phase I | Friedreich's Ataxia (Fa) | Not Yet Recruiting | A Study of SGT-212 Gene Therapy in Friedreich's Ataxia | Aug 22, 2025 | ― |
| Sgt-003 | phase1AndPhase2 | Duchenne Muscular Dystrophy | Recruiting | A Study of SGT-003 Gene Therapy in Duchenne Muscular Dystrophy (INSPIRE DUCHENNE) | Nov 14, 2023 | ― |
| Sgt-001 | phase1AndPhase2 | Duchenne Muscular Dystrophy | Active Not Recruiting | Microdystrophin Gene Transfer Study in Adolescents and Children With DMD | Dec 05, 2017 | ― |
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Solid Biosciences (SLDB) have in its pipeline
Solid Biosciences SLDB is currently developing the following drugs: Sgt-003, Sgt-501, Sgt-212, Sgt-001. These drug candidates are in various stages of clinical development as the company works toward FDA approval.